Neurogene (NGNE) Treasury Shares (2013 - 2026)
Neurogene (NGNE) posted Treasury Shares of $252124.0 for Q1 2026, down 1.65% on a QoQ basis from $256361.0 in Q4 2025, and little changed year-over-year from $252124.0 in Q1 2025.
Neurogene (NGNE) Treasury Shares (2013 - 2026) Analysis & Trends
Neurogene's Treasury Shares history runs 9 years deep, the most recent figure standing at $252124.0 for Q1 2026.
- Quarterly Treasury Shares changed 0.0% year-over-year to $252124.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $252124.0 (changed 0.0% YoY) and the FY2025 annual result came in at $256361.0, up 1.68% from the prior year.
- Treasury Shares was $252124.0 for Q1 2026 at Neurogene, down from $256361.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $18.6 million in Q3 2023 and bottomed at $252124.0 in Q4 2024.
- A 5-year average of $4.4 million and a median of $465931.5 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares surged 3995.69% — and 2024, when it tumbled 97.43%.
- Neurogene's Treasury Shares stood at $13.3 million in 2022, then soared by 39.98% to $18.6 million in 2023, then slumped by 98.64% to $252124.0 in 2024, then rose by 1.68% to $256361.0 in 2025, then slipped by 1.65% to $252124.0 in 2026.
- Business Quant data shows NGNE's Treasury Shares at $252124.0 in Q1 2026, $256361.0 in Q4 2025, and $252124.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | 252,124.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 252,124.00 |
| Mar 31, 2026 | 252,124.00 |
| Dec 31, 2025 | 256,361.00 |
| Dec 31, 2025 | 256,361.00 |
| Sep 30, 2025 | 252,124.00 |
| Sep 30, 2025 | 252,124.00 |
| Jun 30, 2025 | 252,124.00 |
| Jun 30, 2025 | 252,124.00 |
| Mar 31, 2025 | 252,124.00 |
| Mar 31, 2025 | 252,124.00 |
| Dec 31, 2024 | 252,124.00 |
| Dec 31, 2024 | 252,124.00 |
| Sep 30, 2024 | 477,613.00 |
| Sep 30, 2024 | 477,613.00 |
| Sep 30, 2023 | 18.60 Mn |
| Sep 30, 2023 | 18.60 Mn |
| Jun 30, 2023 | 13.29 Mn |
| Jun 30, 2023 | 13.29 Mn |
| Mar 31, 2023 | 13.29 Mn |
| Mar 31, 2023 | 13.29 Mn |